| Date | Filer | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.